Clinical Trial Update: MK0524A Clinical Efficacy Study (0524A-026)(COMPLETED) [Phase 2]

View source ↗

Summary

This update summarizes the completed Phase 2 efficacy study (0524A-026) of MK0524A for hypercholesterolemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• MK0524A

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED